No coin nor oath required. For personal study only.
Chair of the Educational Meetings Committee, has set July 15, 1991, as the deadline for submission of notice of intent to present an educational/informative exhibit.
Educational/informative exhibits may deal with any topic pertinent to emergency medicine. For example, exhibits may display new developments; demonstrate concepts or techniques; review important research findings; or share personal experiences relating to the practice of emergency medicine. Space will be limited.
Exhibits may be sponsored only by an emergency medicine residency program; other 501 (c) (6) or 501 (c) (3) research/educational institution; or an individual. No specific product or commercial service may be represented or promoted. This exhibit session is not intended to function primarily as a forum for the presentation of original research results; however, exhibits that present preliminary data from research in progress may be considered for acceptance. Posters will not be accepted for presentation as educational/informative exhibits. For presentation of original research, a separate area is available for posters only. Poster presentations are not competitive.
Exhibits will be judged based on originality, presentation, educational value, and scientific content. Judges will be appointed by the Chair of the ACEP Educational Meetings Committee. The judgment of the Educational Meetings Committee is final.
The winning exhibit will be presented with an appropriate citation and a cash award during the Scientific Assembly.
Letters of intent and/or inquiries for information concerning educational/informative exhibits should be submitted to: Exhibits Manager, ACEP,
๐ SIMILAR VOLUMES
Exhibits will be judged based on originality, presentation, educational value, and scientific content. Judges will be appointed by the Chair of the ACEP Educational Meetings Committee. The judgment of the Educational Meetings Committee is final. The winning exhibit will be presented with an appropr
Dihydroergotamine is an alpha adrenergic blocking agent with a direct stimuJating effect on the smooth muscle of peripheral and cranial blood vessels, and produces depression of central vasomotor centers. The compound also has the properties of serotonin antagonism. In comparison to ergotamine, the